DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MITCHELL IAN S, XU RUI, XIAO DENGMING, BENCSIK JOSEF R, SPENCER KEITH LEE, KALLAN NICHOLAS C, BLAKE JAMES F
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MITCHELL IAN S
XU RUI
XIAO DENGMING
BENCSIK JOSEF R
SPENCER KEITH LEE
KALLAN NICHOLAS C
BLAKE JAMES F
description The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2015191479A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2015191479A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2015191479A13</originalsourceid><addsrcrecordid>eNrjZLBw8fSIdAnydwsN8lcIiAzy9PV08fRzDVZwBCLvEIWAIP8QV08_BW9PP8dgVwVPPw9PJ88Q_6BgHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSHxpsZGBoamhpaGJu6WhoTJwqADCnKcg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS</title><source>esp@cenet</source><creator>MITCHELL IAN S ; XU RUI ; XIAO DENGMING ; BENCSIK JOSEF R ; SPENCER KEITH LEE ; KALLAN NICHOLAS C ; BLAKE JAMES F</creator><creatorcontrib>MITCHELL IAN S ; XU RUI ; XIAO DENGMING ; BENCSIK JOSEF R ; SPENCER KEITH LEE ; KALLAN NICHOLAS C ; BLAKE JAMES F</creatorcontrib><description>The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150709&amp;DB=EPODOC&amp;CC=US&amp;NR=2015191479A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150709&amp;DB=EPODOC&amp;CC=US&amp;NR=2015191479A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MITCHELL IAN S</creatorcontrib><creatorcontrib>XU RUI</creatorcontrib><creatorcontrib>XIAO DENGMING</creatorcontrib><creatorcontrib>BENCSIK JOSEF R</creatorcontrib><creatorcontrib>SPENCER KEITH LEE</creatorcontrib><creatorcontrib>KALLAN NICHOLAS C</creatorcontrib><creatorcontrib>BLAKE JAMES F</creatorcontrib><title>DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS</title><description>The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBw8fSIdAnydwsN8lcIiAzy9PV08fRzDVZwBCLvEIWAIP8QV08_BW9PP8dgVwVPPw9PJ88Q_6BgHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSHxpsZGBoamhpaGJu6WhoTJwqADCnKcg</recordid><startdate>20150709</startdate><enddate>20150709</enddate><creator>MITCHELL IAN S</creator><creator>XU RUI</creator><creator>XIAO DENGMING</creator><creator>BENCSIK JOSEF R</creator><creator>SPENCER KEITH LEE</creator><creator>KALLAN NICHOLAS C</creator><creator>BLAKE JAMES F</creator><scope>EVB</scope></search><sort><creationdate>20150709</creationdate><title>DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS</title><author>MITCHELL IAN S ; XU RUI ; XIAO DENGMING ; BENCSIK JOSEF R ; SPENCER KEITH LEE ; KALLAN NICHOLAS C ; BLAKE JAMES F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2015191479A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MITCHELL IAN S</creatorcontrib><creatorcontrib>XU RUI</creatorcontrib><creatorcontrib>XIAO DENGMING</creatorcontrib><creatorcontrib>BENCSIK JOSEF R</creatorcontrib><creatorcontrib>SPENCER KEITH LEE</creatorcontrib><creatorcontrib>KALLAN NICHOLAS C</creatorcontrib><creatorcontrib>BLAKE JAMES F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MITCHELL IAN S</au><au>XU RUI</au><au>XIAO DENGMING</au><au>BENCSIK JOSEF R</au><au>SPENCER KEITH LEE</au><au>KALLAN NICHOLAS C</au><au>BLAKE JAMES F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS</title><date>2015-07-09</date><risdate>2015</risdate><abstract>The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2015191479A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A49%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MITCHELL%20IAN%20S&rft.date=2015-07-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2015191479A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true